Literature DB >> 122652

Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.

H Harders1, E Cohnen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 122652      PMCID: PMC1543601     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  8 in total

1.  Letter: Treatment of Wilson's disease.

Authors:  K Gibbs; J M Walshe
Journal:  Br Med J       Date:  1975-12-20

2.  Letter: More on "orphan" drugs.

Authors:  W H Lyle
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

3.  Letter: "Orphan-drug" development - whose responsibility?

Authors:  C M Peterson; A Cerami
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

4.  Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease.

Authors:  H B Dixon; K Gibbs; J M Walshe
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

5.  Triethylene tetramine dihydrochloride in Wilson's disease.

Authors:  R S Dubois; D O Rodgerson; T L Slovis; K M Hambidge; T A Bianchi
Journal:  Lancet       Date:  1970-10-10       Impact factor: 79.321

6.  Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.

Authors:  J M Walshe
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

7.  Wilson's disease: modification by L-DOPA.

Authors:  H J Gelmers; J Troost; J Willemse
Journal:  Neuropadiatrie       Date:  1973-12

8.  Letter: Treatment of Wilson's disease.

Authors:  I Bucur; K H Hasselgren
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

  8 in total
  1 in total

1.  Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo.

Authors:  Ji-Ming Yin; Li-Bo Sun; Jia-Sheng Zheng; Xin-Xin Wang; De-Xi Chen; Ning Li
Journal:  Inflamm Res       Date:  2016-09-09       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.